Assertio Holdings, Inc. – NASDAQ:ASRT
Assertio Holdings stock price today
$0.799
-0.09
-10.41%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 9 hours
Assertio Holdings stock price monthly change
-46.33%
month
Assertio Holdings stock price quarterly change
-46.33%
quarter
Assertio Holdings stock price yearly change
-19.73%
year
Assertio Holdings key metrics
Market Cap | 83.09M |
Enterprise value | 283.52M |
P/E | 2.82 |
EV/Sales | 1.81 |
EV/EBITDA | 3.91 |
Price/Sales | 1.80 |
Price/Book | 1.24 |
PEG ratio | N/A |
EPS | -3.92 |
Revenue | 142.05M |
EBITDA | 27.24M |
Income | -332.96M |
Revenue Q/Q | -23.59% |
Revenue Y/Y | -12.40% |
Profit margin | 70.17% |
Oper. margin | 37.18% |
Gross margin | 88% |
EBIT margin | 37.18% |
EBITDA margin | 19.18% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAssertio Holdings stock price history
Assertio Holdings stock forecast
Assertio Holdings financial statements
| Jun 2023 | 40.99M | 8.47M | 20.66% |
|---|---|---|---|
| Sep 2023 | 35.62M | -279.54M | -784.64% |
| Dec 2023 | 32.98M | -57.38M | -173.97% |
| Mar 2024 | 32.44M | -4.51M | -13.9% |
| Dec 2023 | 32.98M | -57.38M | -173.97% |
|---|---|---|---|
| Mar 2024 | 32.44M | -4.51M | -13.9% |
| Sep 2025 | 33.02M | 3.79M | 11.5% |
| Dec 2025 | 34.22M | 4.27M | 12.49% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 405179000 | 150.90M | 37.24% |
|---|---|---|---|
| Sep 2023 | 380028000 | 187.15M | 49.25% |
| Dec 2023 | 286419000 | 148.41M | 51.82% |
| Mar 2024 | 281965000 | 147.47M | 52.3% |
| Jun 2023 | 18.60M | -703K | -16.32M |
|---|---|---|---|
| Sep 2023 | 2.57M | 4.14M | -10K |
| Dec 2023 | 5.70M | -239K | -8.91M |
| Mar 2024 | 7.50M | 0 | -206K |
Assertio Holdings alternative data
| Aug 2023 | 30 |
|---|---|
| Sep 2023 | 30 |
| Oct 2023 | 30 |
| Nov 2023 | 30 |
| Dec 2023 | 30 |
| Jan 2024 | 30 |
| Feb 2024 | 30 |
| Mar 2024 | 53 |
| Apr 2024 | 53 |
| May 2024 | 53 |
| Jun 2024 | 53 |
| Jul 2024 | 53 |
Assertio Holdings other data
21.90%
+5.80%
of ASRT is owned by hedge funds
48
+10
9.45M
+2.19M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Mar 2024 | 0 | 10251 |
| Jun 2024 | 35000 | 0 |
| Nov 2024 | 86706 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | MASON HEATHER L director | Common Stock | 75,000 | $0.8 | $60,000 | ||
Purchase | O'GRADY BRENDAN P. director, officer.. | Common Stock | 11,706 | $0.85 | $9,950 | ||
Option | SCHLESSINGER SAM officer: SVP, General Counsel | Common Stock | 19,404 | N/A | N/A | ||
Option | SCHLESSINGER SAM officer: SVP, General Counsel | Restricted Stock Units | 19,404 | N/A | N/A | ||
Purchase | VACIRCA JEFF L director | Common Stock | 10,000 | $1.11 | $11,100 | ||
Purchase | MASON HEATHER L director, officer: Interim Exec.. | Common Stock | 25,000 | $0.97 | $24,250 | ||
Option | SCHLESSINGER SAM officer: SVP, General Counsel | Common Stock | 38,017 | N/A | N/A | ||
Option | SCHLESSINGER SAM officer: SVP, General Counsel | Restricted Stock Units | 38,017 | N/A | N/A | ||
Option | SCHWICHTENBERG PAUL officer: SVP, CCO | Common Stock | 38,017 | N/A | N/A | ||
Option | SCHWICHTENBERG PAUL officer: SVP, CCO | Restricted Stock Units | 38,017 | N/A | N/A |
| Quarter | Transcript |
|---|---|
| Q1 2024 6 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 11 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 8 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 3 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. Daniel A. Peisert (1975) Pres, Chief Executive Officer & Director | $609,110 |
Assertio Holdings: Here's A Contrarian Opportunity In The Health Care Sector
Assertio Holdings: Uncovering A Tapestry Of Trading Opportunities From This Oversold Ticker
Growth And Pain Make Assertio A Deep Value Buy
Assertio Holdings Is Back As A High-Value Play
Buy Spectrum Pharmaceuticals For Exposure To Assertio Holdings
Spectrum's Rolvedon A Differentiator In A $3B/Yr Market
Assertio: Cheap And Growing Disruptor Of Pharma's Antiquated Sales Model
Assertio Holdings: A Little More Risk, A Lot Higher Reward
Assertio Holdings Stock Is Still A Cheap Buy
-
What's the price of Assertio Holdings stock today?
One share of Assertio Holdings stock can currently be purchased for approximately $0.8.
-
When is Assertio Holdings's next earnings date?
Unfortunately, Assertio Holdings's (ASRT) next earnings date is currently unknown.
-
Does Assertio Holdings pay dividends?
No, Assertio Holdings does not pay dividends.
-
How much money does Assertio Holdings make?
Assertio Holdings has a market capitalization of 83.09M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 2.67% to 152.07M US dollars.
-
What is Assertio Holdings's stock symbol?
Assertio Holdings, Inc. is traded on the NASDAQ under the ticker symbol "ASRT".
-
What is Assertio Holdings's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Assertio Holdings?
Shares of Assertio Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Assertio Holdings's key executives?
Assertio Holdings's management team includes the following people:
- Mr. Daniel A. Peisert Pres, Chief Executive Officer & Director(age: 50, pay: $609,110)
-
How many employees does Assertio Holdings have?
As Jul 2024, Assertio Holdings employs 53 workers.
-
When Assertio Holdings went public?
Assertio Holdings, Inc. is publicly traded company for more then 27 years since IPO on 3 Dec 1997.
-
What is Assertio Holdings's official website?
The official website for Assertio Holdings is assertiotx.com.
-
Where are Assertio Holdings's headquarters?
Assertio Holdings is headquartered at 100 South Saunders Road, Lake Forest, IL.
-
How can i contact Assertio Holdings?
Assertio Holdings's mailing address is 100 South Saunders Road, Lake Forest, IL and company can be reached via phone at +224 4197106.
Assertio Holdings company profile:
Assertio Holdings, Inc.
assertiotx.comExchange:
NASDAQ
Full time employees:
53
Industry:
Drug Manufacturers - Specialty & Generic
Sector:
Healthcare
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for the treatment of migraine, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate acute pain; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; and Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat adults with severe, active rheumatoid arthritis, and children with active polyarticular juvenile idiopathic arthritis. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 1995 and is headquartered in Lake Forest, Illinois.
100 South Saunders Road
Lake Forest, IL 60045
Lake Forest, IL 60045
CIK: 0001808665
ISIN: US04546C2052
CUSIP: 04546C205
